RxCompounded

Compoundedtirzepatide

[AJ to confirm]

Contains tirzepatide, prescribed for weight management if appropriate
Compounded by a state-licensed pharmacy — no FDA premarket review
Clinician-guided treatment with ongoing support

A compounded GLP-1 medication containing tirzepatide, prepared by a state-licensed pharmacy and prescribed for weight management when a licensed clinician judges it appropriate. It is a weekly injection from a vial, and the amount you take is set and adjusted by your provider over time rather than fixed in advance.

Get started

Important safety information

No membership feeFree, discreet delivery

How to take it?

Use your treatment exactly as directed by your licensed provider. Your provider will determine the appropriate dose, schedule, and method of use based on your health history and treatment plan. You’ll receive medication-specific instructions with your treatment, and your care team is available through secure messaging if you have questions along the way.

What are the possible side effects?

This is a compounded medication. It is prepared by a state-licensed pharmacy and has not undergone FDA premarket review: the FDA does not review compounded preparations for safety, effectiveness or quality in the way it reviews approved drug products, and a compounded preparation should not be assumed to be therapeutically equivalent to any approved product. Side effects vary from person to person. Tirzepatide commonly causes nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, injection-site reactions, fatigue, dizziness, hair loss, and reflux. More serious risks can include pancreatitis, gallbladder problems, kidney injury related to dehydration, severe gastrointestinal reactions, allergic reactions, low blood sugar when taken with insulin or a sulfonylurea, and diabetic retinopathy complications in people with type 2 diabetes. Tirzepatide carries a boxed warning regarding the potential risk of thyroid C-cell tumors and should not be used in people with a personal or family history of medullary thyroid carcinoma or MEN 2. Tirzepatide delays gastric emptying, which can affect the absorption of other oral medicines — including oral contraceptives — and raises the risk of retained gastric contents and pulmonary aspiration during general anesthesia or deep sedation; tell every provider treating you, including your anesthesiologist and your surgeon, that you are taking it. Your licensed provider will review your medical history, discuss risks and contraindications, and provide medication-specific safety information before prescribing. Seek prompt medical care for severe or concerning symptoms.

Talk to your provider about any side effects you experience.

What does Koves offer?

Protocols built around you, with dose adjustments if needed
Fast online visit, reviewed by a licensed provider
24/7 secure messaging plus check-ins with your care team
Medication delivered straight to your door — no pharmacy lines
Every plan includes supplies, free shipping, prescription if eligible, and ongoing medical support

Pricing to confirm. Compounded medications do not undergo FDA premarket review and require a prescription from a licensed provider who decides whether treatment is appropriate.

Prepared and dispensed by an independent state-licensed pharmacy. [AJ to confirm: VialsRx — legal name and 503A/503B facility class outstanding from Bask.] Koves does not compound, manufacture or dispense medication.

Diagram: tirzepatide docking into two different receptors

It contains tirzepatide.

Tirzepatide acts on two gut-hormone receptors rather than one — GIP as well as GLP-1 — which is what distinguishes the molecule from the single-receptor GLP-1s.

Diagram: a mortar and pestle beside a vial — the compounding pharmacy

It is compounded, not approved.

A state-licensed pharmacy prepares it. The FDA does not review compounded preparations the way it reviews approved drug products, and it should not be assumed to be therapeutically equivalent to one.

Diagram: a chart and a stethoscope, one dose marked and stepped up

Your provider sets the amount.

There is no fixed schedule published here. A licensed clinician decides where you start and changes it based on how you respond.

Diagram: a calendar with one day marked, beside a vial

One injection a week.

A fixed day, whenever suits. In published trials of tirzepatide, adults with obesity or overweight lost substantial body weight over 72 weeks.¹

Get started

1. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022 (SURMOUNT-1). See source

Figures describe published trials of the molecule and the study populations enrolled in them. Compounded preparations were not studied in those trials, have not been compared with any approved product, and results vary from person to person. Koves is a technology platform that facilitates access to independent licensed medical providers and does not practice medicine, compound or dispense. Treatment decisions are made solely by independent licensed providers following a clinical evaluation. Individual results may vary.

One price.Everything in it.

Along with the medication, if prescribed, you get:

A licensed provider who reviews every visit
Dose changes whenever your provider judges they are needed
24/7 secure messaging with your care team
Free, discreet delivery in plain packaging
No membership fee

Get started

Compounded prescription products require an online consultation with a licensed clinician who will determine whether a prescription is appropriate.

Your provider sets the starting amount and adjusts it over time based on how you respond. Dosing is not published here because it is individual and clinical.

A single vial of compounded tirzepatide small in a wide amber frame, the ground falling into shadow

A provider decides,not a price list.

Whether a compounded medication is appropriate for you is a clinical judgment, made by the licensed clinician who reviews your visit.

Start your visit

Two compounded options.Which one is yours?

Both are compounded preparations dispensed by an independent state-licensed pharmacy. Neither has undergone FDA premarket review, neither has been compared with the other in a clinical trial, and which one is appropriate — if either is — is your provider’s decision. Prepared and dispensed by an independent state-licensed pharmacy. [AJ to confirm: VialsRx — legal name and 503A/503B facility class outstanding from Bask.] Koves does not compound, manufacture or dispense medication.

Both are compounded GLP-1 medications prescribed for weight management. A provider reviews your visit and decides which, if either, fits.

Compounded tirzepatide

Form: Injectable vial
How to take: Weekly injection
Contains: Tirzepatide
Dosing: Set by your provider
Prescribed for: Weight management
Starts at: [AJ to confirm]

Compounded semaglutide

Form: Injectable vial
How to take: Weekly injection
Contains: Semaglutide
Dosing: Set by your provider
Prescribed for: Weight management
Starts at: [AJ to confirm]

Frequently asked questions about compounded tirzepatide

Get started

What is a compounded medication?

One prepared by a licensed pharmacy for an individual patient, rather than manufactured and sold as an approved drug product. Compounded preparations do not undergo FDA premarket review: the agency does not review them for safety, effectiveness or quality in the way it reviews approved products, and they should not be assumed to be therapeutically equivalent to one.

Who prepares it?

An independent state-licensed pharmacy prepares and dispenses it. Koves does not compound, manufacture or dispense medication — it is a technology platform that connects you with independent licensed providers and pharmacies.

How is it taken?

One injection a week, from a vial, on a day you pick. Your provider sets the amount you start on and adjusts it over time based on how you respond, so there is no schedule published here to read ahead of that conversation.

What does tirzepatide actually do?

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Both are gut hormones released after eating; acting on the pair together slows stomach emptying and lowers appetite.

What are the common side effects?

Nausea, diarrhoea, vomiting, constipation, stomach pain and injection-site reactions are the frequent ones. Serious risks include pancreatitis, gallbladder problems and kidney injury from dehydration. Tirzepatide carries a boxed warning about thyroid C-cell tumours. Your provider goes through the full list before prescribing.

Who should not take it?

Anyone with a personal or family history of medullary thyroid carcinoma, or with MEN 2. Tell every provider treating you — including your anesthesiologist and surgeon before any procedure — that you are taking a GLP-1 medication, because it delays gastric emptying. If you take an oral contraceptive, ask your provider about absorption.

What happens if I stop?

Appetite generally returns to where it was, and weight often follows. This is a long-term treatment, and stopping is a conversation to have with your provider rather than a decision to make alone.

Someone caught mid-movement in warm daylight at home

Turns out…

the next step was closer than it felt.

Start your visit

Compounded prescription products require an online consultation with a licensed clinician who will determine whether a prescription is appropriate. **Compounded medications do not undergo FDA premarket review.** The FDA does not review compounded preparations for safety, effectiveness or quality in the way it reviews approved drug products. A compounded preparation should not be assumed to be therapeutically equivalent to any approved product. Whether one is appropriate is decided solely by the treating provider. Rx required.